Comparison of Prasugrel and Clopidogrel in Thrombotic Stroke Patients with Risk Factors for Ischemic Stroke Recurrence: An Integrated Analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-III
Takanari Kitazono(Kyushu University), Kazumi Kimura(Nippon Medical School), Atsushi Takita(Daiichi-Sankyo (Japan)), Yuji Matsumaru(University of Tsukuba), Masahiro Kamouchi(Kyushu University), Toshiaki Shirai(University of Yamanashi), Takeshi Kuroda(Daiichi-Sankyo (Japan))
Cited by 10
Related Papers
Secular Trends in Cardiovascular Disease and Its Risk Factors in Japanese
|Circulation|2013|287
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
|The Lancet Neurology|2019|216
Postischemic Gene Transfer of Interleukin-10 Protects Against Both Focal and Global Brain Ischemia
|Circulation|2005|201
Proteinuria and clinical outcomes after ischemic stroke
|Neurology|2012|198